Clinical Biochemistry and Metabolism - Issue 2/2016
63
The verification of the applicability of NPHS2/SYNPO ratio for diagnosis of FSGS and MCD
M. Šafaříková, E. Pazourková, A. Hořínek, J. Reiterová, D. Maixnerová, E. Honsová, J. Zadražil, J. Štekrová, M. Kohoutová, V. Tesař
67
Activity of phosphomannomutase 2 in patients with suspected congenital disorder of glycosylation
H. Hansíková, N. Ondrušková, T. Honzík, K. Veselá, E. Horová, Š. Švecová, M. Tesařová, J. Zeman
75
Quality, control and validation of glucometers and CGM systems. Status overview
B. Friedecký, J. Kratochvíla, D. Springer
82
Postanalytical phase and interpretation of laboratory tests
T. Šálek, J. Franeková, A. Jabor, B. Friedecký
88
Changes in Paraoxonase 1 activity and concentration of conjugated dienes in connection with number of metabolic syndrome components
B. Staňková, L. Vávrová, J. Rychlíková, A. Žák
Clinical Biochemistry and Metabolism
2016 Číslo 2
Najčítanejšie v tomto čísle
- Quality, control and validation of glucometers and CGM systems. Status overview
- Postanalytical phase and interpretation of laboratory tests
- Activity of phosphomannomutase 2 in patients with suspected congenital disorder of glycosylation
- The verification of the applicability of NPHS2/SYNPO ratio for diagnosis of FSGS and MCD